Product

Tirzepatide




Introduction

Tirzepatide,  is a medication used for the treatment of type 2 diabetes.

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control.  After a person has eaten, these hormones are secreted by cells of the intestines and in turn cause the secretion of insulin. Tirzepatide is a GIP-analogue which activates both the GLP-1 and GIP receptors, leading to improved blood sugar control..

Tirzepatide is a glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist that integrates the two insulin-stimulating effects into a single molecule. Through a dual mechanism of action to activate the hormone receptors involved in blood glucose control -GIP and GLP-1 two incretin receptors.


Product Name

Tirzepatide

Other Names

LY3298176, GIP/GLP-1 RA

CAS No.

2023788-19-2

Molecular formula

C225H348N48O68

Molecular weight

4813.8

Storage

28°C

Apperance

White to off white powder or loose lump

Purity

98.0%



Function:

1. Significantly reduce glycemic levels

2. Improve insulin sensitivity

3. Reducing body weight

4. Improving lipid metabolism


Our advantage

  •        Leading peptide manufacturer in China
  •        High Technology Enterprise Award
  •        GMP standard workshop
  •        High purity peptide
  •        Competitive price and excellent service
  •        Shorter production cycle






Previous:Semaglutide
Next:GHRP-6

Copyright(C)2022, Sichuan Jisheng Biopharmaceutical Co.,Ltd All Rights Reserved.